86 related articles for article (PubMed ID: 11740185)
1. Conserved CXCR4 usage and enhanced replicative capacity of HIV-2/287, an isolate highly pathogenic in Macaca nemestrina.
Rey-Cuille MA; Hu SL
AIDS; 2001 Dec; 15(18):2349-57. PubMed ID: 11740185
[TBL] [Abstract][Full Text] [Related]
2. Derivation and characterization of a highly pathogenic isolate of human immunodeficiency virus type 2 that causes rapid CD4+ cell depletion in Macaca nemestrina.
McClure J; Schmidt AM; Rey-Cuille MA; Bannink J; Misher L; Tsai CC; Anderson DM; Morton WR; Hu SL
J Med Primatol; 2000 Aug; 29(3-4):114-26. PubMed ID: 11085573
[TBL] [Abstract][Full Text] [Related]
3. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.
Zhang Y; Lou B; Lal RB; Gettie A; Marx PA; Moore JP
J Virol; 2000 Aug; 74(15):6893-910. PubMed ID: 10888629
[TBL] [Abstract][Full Text] [Related]
4. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals.
Nokta MA; Li XD; Nichols J; Mallen M; Pou A; Asmuth D; Pollard RB
AIDS; 2001 Jan; 15(2):161-9. PubMed ID: 11216923
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of HIV-2 strains obtained from asymptomatic patients that do not use CCR5 or CXCR4 coreceptors.
Azevedo-Pereira JM; Santos-Costa Q; Mansinho K; Moniz-Pereira J
Virology; 2003 Aug; 313(1):136-46. PubMed ID: 12951028
[TBL] [Abstract][Full Text] [Related]
6. Characterization of HIV-2 chimeric viruses unable to use CCR5 and CXCR4 coreceptors.
Santos-Costa Q; Mansinho K; Moniz-Pereira J; Azevedo-Pereira JM
Virus Res; 2009 Jun; 142(1-2):41-50. PubMed ID: 19200444
[TBL] [Abstract][Full Text] [Related]
7. CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates.
Mörner A; Björndal A; Leandersson AC; Albert J; Björling E; Jansson M
AIDS Res Hum Retroviruses; 2002 Feb; 18(3):193-200. PubMed ID: 11839153
[TBL] [Abstract][Full Text] [Related]
8. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
Chen Z; Gettie A; Ho DD; Marx PA
Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
[TBL] [Abstract][Full Text] [Related]
9. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
[TBL] [Abstract][Full Text] [Related]
10. Differential replication and pathogenic effects of HIV-1 and HIV-2 in Macaca nemestrina.
Otten RA; Brown BG; Simon M; Lupo LD; Parekh BS; Lairmore MD; Schable CA; Schochetman G; Rayfield MA
AIDS; 1994 Mar; 8(3):297-306. PubMed ID: 8031510
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
[TBL] [Abstract][Full Text] [Related]
12. Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.
Beaumont T; Broersen S; van Nuenen A; Huisman HG; de Roda Husman AM; Heeney JL; Schuitemaker H
J Virol; 2000 Sep; 74(17):7699-707. PubMed ID: 10933675
[TBL] [Abstract][Full Text] [Related]
13. HIV-2 interaction with cell coreceptors: amino acids within the V1/V2 region of viral envelope are determinant for CCR8, CCR5 and CXCR4 usage.
Santos-Costa Q; Lopes MM; Calado M; Azevedo-Pereira JM
Retrovirology; 2014 Nov; 11():99. PubMed ID: 25421818
[TBL] [Abstract][Full Text] [Related]
14. Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells.
Owen SM; Masciotra S; Novembre F; Yee J; Switzer WM; Ostyula M; Lal RB
J Virol; 2000 Jun; 74(12):5702-8. PubMed ID: 10823878
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent.
McKnight A; Wilkinson D; Simmons G; Talbot S; Picard L; Ahuja M; Marsh M; Hoxie JA; Clapham PR
J Virol; 1997 Feb; 71(2):1692-6. PubMed ID: 8995702
[TBL] [Abstract][Full Text] [Related]
16. Serial in vivo passage of HIV-1 infection in Macaca nemestrina.
Agy MB; Schmidt A; Florey MJ; Kennedy BJ; Schaefer G; Katze MG; Corey L; Morton WR; Bosch ML
Virology; 1997 Nov; 238(2):336-43. PubMed ID: 9400606
[TBL] [Abstract][Full Text] [Related]
17. Infection of macaques with an R5-tropic SHIV bearing a chimeric envelope carrying subtype E V3 loop among subtype B framework.
Kaizu M; Sato H; Ami Y; Izumi Y; Nakasone T; Tomita Y; Someya K; Takebe Y; Kitamura K; Tochikubo O; Honda M
Arch Virol; 2003 May; 148(5):973-88. PubMed ID: 12721803
[TBL] [Abstract][Full Text] [Related]
18. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression.
Xiao L; Rudolph DL; Owen SM; Spira TJ; Lal RB
AIDS; 1998 Sep; 12(13):F137-43. PubMed ID: 9764773
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic microangiopathy in the HIV-2-infected macaque.
Eitner F; Cui Y; Hudkins KL; Schmidt A; Birkebak T; Agy MB; Hu SL; Morton WR; Anderson DM; Alpers CE
Am J Pathol; 1999 Aug; 155(2):649-61. PubMed ID: 10433958
[TBL] [Abstract][Full Text] [Related]
20. Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor.
Calado M; Matoso P; Santos-Costa Q; Espirito-Santo M; Machado J; Rosado L; Antunes F; Mansinho K; Lopes MM; Maltez F; Santos-Ferreira MO; Azevedo-Pereira JM
Virology; 2010 Dec; 408(2):174-82. PubMed ID: 20947116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
